Edition:
India

Aceto Corp (ACET.OQ)

ACET.OQ on NASDAQ Stock Exchange Global Select Market

2.47USD
24 Apr 2018
Change (% chg)

$0.19 (+8.33%)
Prev Close
$2.28
Open
$2.32
Day's High
$2.48
Day's Low
$2.32
Volume
288,736
Avg. Vol
159,346
52-wk High
$17.10
52-wk Low
$2.22

Select another date:

Wed, Feb 28 2018

BRIEF-Aceto To Appeal U.S. Government Ruling Regarding Certain Lucid Pharma Contracts

* ACETO TO APPEAL U.S. GOVERNMENT RULING REGARDING CERTAIN LUCID PHARMA CONTRACTS

BRIEF-Aceto Appoints Edward Borkowski Chief Financial Officer

* ACETO CORP - APPOINTS EDWARD BORKOWSKI AS CFO EFFECTIVE FEB 21, 2018 Source text for Eikon: Further company coverage:

BRIEF-Aceto Subsidiary, Rising Pharmaceuticals, Launches Atenolol Tablets, 25Mg, 50Mg And 100Mg

* ACETO SUBSIDIARY, RISING PHARMACEUTICALS, LAUNCHES ATENOLOL TABLETS, 25MG, 50MG AND 100MG

BRIEF-Aceto Q2 Loss Per Share $0.39

* IN QUARTER, NET LOSS INCLUDES $13.9 MILLION OF ADDITIONAL INCOME TAX EXPENSE ASSOCIATED WITH TAX CUTS AND JOBS ACT

BRIEF-Aceto's Unit Launches Efavirenz Capsules, 50Mg, 200Mg

* ACETO SUBSIDIARY, RISING PHARMACEUTICALS, LAUNCHES EFAVIRENZ CAPSULES, 50MG AND 200MG

BRIEF-Aceto reports fiscal 2018 first quarter results

* Q1 earnings per share view $0.29 -- Thomson Reuters I/B/E/S

BRIEF-Aceto corp CFO Douglas Roth notifies co he will retire effective March 31, 2018​

* Says on October 26, Douglas Roth, Chief Financial Officer of Aceto Corporation notified company that he will retire effective March 31, 2018​ Source text : ( http://bit.ly/2yQZ0rq ) Further company coverage:

Select another date: